White blood cell monitoring during treatment cycles

Abstract

This application relates to methods and apparatus for monitoring and predicting a cell count of at least one component of white blood cells, especially absolute neutrophil count (ANC), within a chemotherapy treatment cycle. The method comprises taking (102), within a treatment cycle, at least one measurement of a cell count of said white blood cell component of a subject; identifying (103) at least one modeled trajectory of white blood cell count that matches said at least one measurement for said subject; and based on said at least one modeled trajectory identifying (104) a likely cell count at a later date in the cycle and/or start of the next cycle. The step of identifying at least one modeled trajectory may comprise taking a reference set of trajectories that has been generated (101), and from said reference set, identifying a selection set of trajectories that matches the measurement data.

Dependencies are inferred from the claim text.